Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...

Medicare Part D will cover popular weight loss drugs like Wegovy and Ozempic starting in 2026, with copays capped at $50 per ...

Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand ...

In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic ...

Weight loss drug Ozempic has caused quite a stir this year, with many linking it to drastic celebrity weight loss. While ...

Novo Nordisk’s blockbuster diabetes drug, Ozempic, was officially launched in India on December 12. Unlike in the US and ...

The class of GLP-1 agonist medications act by lowering the appetite with applications way beyond diabetes. These medicines ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

Step aside, semaglutide—retatrutide is showing the most impressive weight loss results of any obesity drug to date.

Up to 50 cats are expected to participate in the trial, with their weight and health metrics monitored at three and six ...